Literature DB >> 20496425

Significance of B cells and B cell clonality in Sjögren's syndrome.

Pierre Youinou1, Valérie Devauchelle-Pensec, Jacques-Olivier Pers.   

Abstract

Entities:  

Mesh：

Year:  2010        PMID： 20496425     DOI： 10.1002/art.27564

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN： 0004-3591


× No keyword cloud information.
  18 in total

Review 1.  The Differential Diagnosis of Dry Eyes, Dry Mouth, and Parotidomegaly: A Comprehensive Review.

Authors:  Divi Cornec; Alain Saraux; Sandrine Jousse-Joulin; Jacques-Olivier Pers; Sylvie Boisramé-Gastrin; Yves Renaudineau; Yves Gauvin; Anne-Marie Roguedas-Contios; Steeve Genestet; Myriam Chastaing; Béatrice Cochener; Valérie Devauchelle-Pensec
Journal:  Clin Rev Allergy Immunol       Date:  2015-12       Impact factor: 8.667

2.  Proteasome inhibition suppresses Th17 cell generation and ameliorates autoimmune development in experimental Sjögren's syndrome.

Authors:  Fan Xiao; Xiang Lin; Jie Tian; Xiaohui Wang; Qian Chen; Ke Rui; Jie Ma; Shengjun Wang; Qingwen Wang; Xiaoqi Wang; Dongzhou Liu; Lingyun Sun; Liwei Lu
Journal:  Cell Mol Immunol       Date:  2017-07-10       Impact factor: 11.530

Review 3.  Is it Sjögren's syndrome or burning mouth syndrome? Distinct pathoses with similar oral symptoms.

Authors:  Hawra Aljanobi; Amarpreet Sabharwal; Bralavan Krishnakumar; Jill M Kramer
Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol       Date:  2017-01-24

Review 4.  B-lymphocyte tolerance and effector function in immunity and autoimmunity.

Authors:  Wasif N Khan; Jacqueline A Wright; Eden Kleiman; Justin C Boucher; Iris Castro; Emily S Clark
Journal:  Immunol Res       Date:  2013-12       Impact factor: 2.829

5.  A case for IL-6, IL-17A, and nitric oxide in the pathophysiology of Sjögren's syndrome.

Authors:  Sarah Benchabane; Abdelhalim Boudjelida; Ryma Toumi; Houda Belguendouz; Pierre Youinou; Chafia Touil-Boukoffa
Journal:  Int J Immunopathol Pharmacol       Date:  2016-05-19       Impact factor: 3.219

6.  Rituximab therapy for primary Sjögren's syndrome: an open-label clinical trial and mechanistic analysis.

Authors:  E William St Clair; Marc C Levesque; Eline T Luning Prak; Frederick B Vivino; Chacko J Alappatt; Meagan E Spychala; Josiah Wedgwood; James McNamara; Kathy L Moser Sivils; Lytia Fisher; Philip Cohen
Journal:  Arthritis Rheum       Date:  2013-04

7.  Rationale for treating primary Sjögren's syndrome patients with an anti-CD6 monoclonal antibody (Itolizumab).

Authors:  Christelle Le Dantec; Ruby Alonso; Tinhinane Fali; Enrique Montero; Valérie Devauchelle; Alain Saraux; Jacques-Olivier Pers; Yves Renaudineau
Journal:  Immunol Res       Date:  2013-07       Impact factor: 2.829

Review 8.  Immunopathologic differences of Sjögren's syndrome versus sicca syndrome in HCV and HIV infection.

Authors:  Claudio Vitali
Journal:  Arthritis Res Ther       Date:  2011-08-19       Impact factor: 5.156

Review 9.  Disturbance of cytokine networks in Sjögren's syndrome.

Authors:  Pierre Youinou; Jacques-Olivier Pers
Journal:  Arthritis Res Ther       Date:  2011-07-06       Impact factor: 5.156

Review 10.  B-cell targeted therapeutics in clinical development.

Authors:  Stephan Blüml; Kathleen McKeever; Rachel Ettinger; Josef Smolen; Ronald Herbst
Journal:  Arthritis Res Ther       Date:  2013-04-04       Impact factor: 5.156
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.